(Q36851595)

English

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial

scientific article published on April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 August 2017

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial (English)

1 reference

Europe PubMed Central

16 August 2017

1 reference

based on heuristic

inferred from title

randomized controlled trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jean Wactawski-Wende

13

object named as

Jean Wactawski-Wende

1 reference

Europe PubMed Central

16 August 2017

12

object named as

Cora E Lewis

1 reference

Europe PubMed Central

16 August 2017

Barbara V Howard

11

object named as

Barbara V Howard

1 reference

Europe PubMed Central

16 August 2017

JoAnn E. Manson

3

object named as

JoAnn E Manson

1 reference

Europe PubMed Central

16 August 2017

Marcia L. Stefanick

8

object named as

Marcia L Stefanick

1 reference

Europe PubMed Central

16 August 2017

1

object named as

Andrea Z LaCroix

1 reference

Europe PubMed Central

16 August 2017

Rowan T Chlebowski

2

object named as

Rowan T Chlebowski

1 reference

Europe PubMed Central

16 August 2017

Robert G. Brzyski

9

object named as

Robert Brzyski

1 reference

Europe PubMed Central

16 August 2017

Karen L. Margolis

7

object named as

Karen L Margolis

1 reference

Europe PubMed Central

16 August 2017

Aaron K Aragaki

4

object named as

Aaron K Aragaki

1 reference

Europe PubMed Central

16 August 2017

WHI Investigators

14

object named as

WHI Investigators

1 reference

Europe PubMed Central

16 August 2017

10

object named as

J David Curb

1 reference

Europe PubMed Central

16 August 2017

author name string

Karen C Johnson

5

1 reference

Europe PubMed Central

16 August 2017

Lisa Martin

6

1 reference

Europe PubMed Central

16 August 2017

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

16 August 2017

The Journal of the American Medical Association

1 reference

Europe PubMed Central

16 August 2017

305

1 reference

Europe PubMed Central

16 August 2017

13

1 reference

Europe PubMed Central

16 August 2017

1305-1314

1 reference

Europe PubMed Central

16 August 2017

Breast cancer risk in relation to the interval between menopause and starting hormone therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Breast cancer after use of estrogen plus progestin in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen therapy and coronary-artery calcification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Molecular and cellular basis of cardiovascular gender differences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Breast cancer and hormone-replacement therapy in the Million Women Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Understanding the divergent data on postmenopausal hormone therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen replacement therapy, atherosclerosis, and vascular function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

29 September 2017

Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 September 2018

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656722

4 December 2018

Outcomes ascertainment and adjudication methods in the women's health initiative

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unopposed estrogen therapy and the risk of invasive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of time from menopause and mammography on hormone therapy-related breast cancer risk assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/21467283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2011.382

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36851595&oldid=2063156716"